Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Optoceutics ApS
APS
Active
Advertising protection
CVR 39769689
Nørrebrogade 45C, 2200
København N
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2018 · 7 years old
5 employees
www.optoceutics.com
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Optoceutics ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
6M
3M
0M
-2M
-5M
2021: -2M
-2M
2021
2022: 4M (+300% vs 2021)
4M
+300%
2022
2023: 1M (-75% vs 2022)
1M
-75%
2023
2024: -1M (-200% vs 2023)
-1M
-200%
2024
2025: -3M (-200% vs 2024)
-3M
-200%
2025
EBITDA
DKK millions
0M
-3M
-6M
-8M
-11M
2021: -5M
-5M
2021
2022: -3M (+40% vs 2021)
-3M
+40%
2022
2023: -8M (-167% vs 2022)
-8M
-167%
2023
2024: -9M (-12% vs 2023)
-9M
-12%
2024
2025: -8M (+11% vs 2024)
-8M
+11%
2025
Income statement
DKK thousands
Item
2025
2024
2023
2022
2021
Gross profit
-2.586
-519
910
4.263
-2.177
Staff expenses
-5.115
-8.047
-8.425
-7.569
-3.241
EBITDA
-7.700
-8.566
-7.515
-3.306
-5.418
Depreciation & amort.
-740
-740
-536
-750
-0
EBIT
-8.440
-9.306
-8.051
-4.056
-5.418
Net financials
-765
-762
-583
-996
-68
Profit before tax
-9.205
-10.068
-8.633
-5.052
-5.486
Tax
-469
-884
-1.422
-1.416
-1.606
Net profit
-8.736
-9.185
-7.212
-3.636
-3.880
Balance sheet
DKK thousands
Item
2025
2024
2023
2022
2021
Total assets
43.578
46.023
40.816
29.926
26.446
Equity
32.320
34.064
28.914
16.943
13.367
Long-term debt
1.607
9.861
10.059
9.472
8.500
Short-term debt
9.651
2.098
1.843
2.898
3.570
Total debt
11.257
11.959
11.901
12.370
12.070
Financial ratios
5-year trend
EBITDA margin (of gross profit)
<−999 %
This company
2021
2025
Equity ratio
74,2 %
This company
38,2 %
Market median
This company
Market median
94% above market
2021
2025
Return on equity
-27,0 %
This company
18,4 %
Market median
This company
Market median
247% below market
2021
2025
Net profit margin (of gross profit)
<−999 %
This company
2021
2025
Asset turnover (of gross profit)
-0,06×
This company
2021
2025
Debt / equity
0,35×
This company
0,62×
Market median
This company
Market median
44% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on Optoceutics ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
